Pfizer Covid Vaccines
- All
- News
- Videos
-
What Are mRNA Vaccines That Earned Two Scientists Nobel Prize In Medicine?
This year's Nobel Prize in Medicine has been awarded to scientists for discoveries that enabled the development of mRNA vaccines against COVID-19.
-
Mobile 3D Printer to Produce Thumbnail-Sized mRNA Covid Vaccine Patches Developed by Scientists: Details
A mobile 3D printer to produce thumbnail-sized patches capable of delivering mRNA Covid vaccines has been developed by scientists. The device is likely years away from being available and many hurdles remain, but the tabletop device could help immunise people in remote regions. A 3D printer can create two-centimetre-wide vaccine patches with hundre...
-
Government Blocked Pfizer's Covid Vaccine, Claims KCR In New Attack
Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to "forcefully" prevent import of COVID-19 vaccines from Pfizer, especially when people were ready to get the best vaccine.
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
-
Pfizer-BioNTech To Test Combined Vaccine For Covid, Flu
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
Moderna Sues Pfizer Over Covid Vaccine
Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their shot for COVID-19.
-
Covid Vaccine Scheme For The Poorest Pushes For Delivery Slowdown: Report
Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers,including Pfizer and Moderna, to cut or slow deliveries of about half a billion shots so doses are not wasted.
-
US Approves Covid Vaccines For Children As Young As 6 Months
US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
What Are mRNA Vaccines That Earned Two Scientists Nobel Prize In Medicine?
This year's Nobel Prize in Medicine has been awarded to scientists for discoveries that enabled the development of mRNA vaccines against COVID-19.
-
Mobile 3D Printer to Produce Thumbnail-Sized mRNA Covid Vaccine Patches Developed by Scientists: Details
A mobile 3D printer to produce thumbnail-sized patches capable of delivering mRNA Covid vaccines has been developed by scientists. The device is likely years away from being available and many hurdles remain, but the tabletop device could help immunise people in remote regions. A 3D printer can create two-centimetre-wide vaccine patches with hundre...
-
Government Blocked Pfizer's Covid Vaccine, Claims KCR In New Attack
Telangana Chief Minister K Chandrashekar Rao has alleged that the Central government did everything possible to "forcefully" prevent import of COVID-19 vaccines from Pfizer, especially when people were ready to get the best vaccine.
-
US Probes Risk Of Stroke From Pfizer Covid Vaccine Booster Dose
Earlier this month, US health officials said they had detected the possible link to ischemic strokes in people over age 65 who received the newer booster shots.
-
Pfizer Chief Ignores Questions About Covid Vaccine's Efficacy In Davos: Report
Albert Bourla, Chief Executive Officer of US-based pharmaceutical giant Pfizer, encountered a series of tough questions about the efficacy of its Covid vaccine on the sidelines of the ongoing World Economic Forum, but he repeatedly ignored them.
-
China To Distribute Pfizer Vaccine In Beijing As Covid Cases Surge: Report
As Covid cases in China continue to rise, Beijing will soon start distributing Pfizer's Covid-19 drug Paxlovid to the community health centres in forthcoming days, CNN reported citing state media on Monday.
-
Pfizer-BioNTech To Test Combined Vaccine For Covid, Flu
Pfizer-BioNTech said Thursday they will test a combined coronavirus and influenza vaccine, which could potentially pave the way for better inoculation uptake for both illnesses.
-
AstraZeneca Covid Jab Linked To Higher Risk Of Rare Blood Clot, Finds Study
AstraZeneca's Covid vaccine has been linked to a 30-percent higher risk of getting a very rare blood clotting condition compared to the Pfizer jab, a large international study said on Thursday.
-
Moderna Sues Pfizer Over Covid Vaccine
Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their shot for COVID-19.
-
Covid Vaccine Scheme For The Poorest Pushes For Delivery Slowdown: Report
Leaders of the global scheme aiming to get COVID-19 vaccines to the world's poorest are pushing manufacturers,including Pfizer and Moderna, to cut or slow deliveries of about half a billion shots so doses are not wasted.
-
US Approves Covid Vaccines For Children As Young As 6 Months
US health authorities on Saturday cleared the Pfizer and Moderna Covid-19 vaccines for children aged five and younger, in a move President Joe Biden greeted as a "monumental step" in the fight against the virus.
-
US Approves Covid Vaccine For Children 6 Months And Above
The US Food and Drug Administration granted emergency authorization Friday for the use of Pfizer and Moderna Covid-19 vaccines in the youngest children, the final age group awaiting immunization in most countries.
-
EU Watchdog Reviews Adapted Pfizer Jab. Target: Omicron
Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
-
3 Covid Shots Generate Good Response In Under-5s: Pfizer-BioNTech
The Pfizer-BioNTech Covid-19 vaccine is safe and effective for children aged six months to under five years when given in 3 doses.
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
